Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

An Analysis of the Critical Components That Make up a Pharmaceutical Company.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c60073) has announced the addition of "Takeda Takeda (武田氏 Takeda)  IMS (1) See IP Multimedia Subsystem.

(2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS.
 Company Profile" to their offering.

IMS Health's Company Profiles give you the authoritative insight into a company at a strategic and local level.

Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy.

* Critical analyses provided by an in-house In-house

In the context of general equities, keeping an activity within the firm. For example, rather than go to the marketplace and sell a security for a client to anyone, an attempt is made to find a buyer to complete the transaction with the firm.
 expert team

* 90+ full in-depth company profiles covering all major pharmaceutical companies worldwide including private companies

* Includes some Generic, Biotechnology and Drug Delivery companies

* Includes IMS Health IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow.  sales data on products and therapies

* In depth product and R&D reviews, including clinical trial, lifecycle management, competition and analysts forecasts

* Mergers and acquisitions; licensing agreements

* Forecasts and comments from leading financial analysts

* Companies' conferences, annual reports, press releases

* Comments from stockbrokers/analysts reports used throughout the profile and especially within the Strategy, Financial and Product sections.
Areas covered:

-         Corporate Structure
-         Strategy statement
-         Financial Review
-         Company Sales Performance:
-         Product Portfolio
-         R&D Pipelines
-         Analyst figures
-         Licensing/Co-Marketing Agreements
-         Major Events
-         Subsidiaries listing


For more information visit http://www.researchandmarkets.com/reports/c60073
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company overview
Date:Jun 19, 2007
Words:199
Previous Article:Mentor Corporation Increases Share Repurchase Program by 5 Million Shares; Declares First Quarter Dividend of $0.20 Per Share.
Next Article:An Analysis of the Capacitor Market in North America.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles